Dr. Sumedha Penheiter

So we've tried to be very broad and inclusive to allow for those small groups that want to focus on a certain aspect of this plan. The challenge has been, as you said, it's very broad and And again, COVID didn't help. We lost about five years in this mix with COVID where we were really slowed down.

So we've tried to be very broad and inclusive to allow for those small groups that want to focus on a certain aspect of this plan. The challenge has been, as you said, it's very broad and And again, COVID didn't help. We lost about five years in this mix with COVID where we were really slowed down.

So I think the understanding is that we are going to continue to kind of streamline our efforts based on, as we're developing the plan, reaching out to our partners, ensure that there's commitment at the level that is required to carry out a plan in action. and also resources in place.

So I think the understanding is that we are going to continue to kind of streamline our efforts based on, as we're developing the plan, reaching out to our partners, ensure that there's commitment at the level that is required to carry out a plan in action. and also resources in place.

So the biggest challenge really has been in that space where we just have not had enough resources in terms of human resources to amplify some of the work. So I think that is really the crux of it is the feasibility of it. But I would say there have been successes as well. We've worked aggressively in like the HPV cancer space and really addressed inequities.

So the biggest challenge really has been in that space where we just have not had enough resources in terms of human resources to amplify some of the work. So I think that is really the crux of it is the feasibility of it. But I would say there have been successes as well. We've worked aggressively in like the HPV cancer space and really addressed inequities.

We have a health equity network group, a cancer health equity network group that works very closely with us and has a lot of health equity focused objectives. And so, you know, instead of focusing on one aspect per se, we've really gone through and all, use the inequity as an underlying theme to address a lot of cancers.

We have a health equity network group, a cancer health equity network group that works very closely with us and has a lot of health equity focused objectives. And so, you know, instead of focusing on one aspect per se, we've really gone through and all, use the inequity as an underlying theme to address a lot of cancers.

And so I think that the challenge has been, you know, going from just individual organ focused, really understanding a common health equity theme, which we have overcome successfully now, but it was difficult during the times of COVID. So just, you know, and also the support from, Agencies and lobbying agencies, our policy network has done a lot of work to lobby for some of those things.

And so I think that the challenge has been, you know, going from just individual organ focused, really understanding a common health equity theme, which we have overcome successfully now, but it was difficult during the times of COVID. So just, you know, and also the support from, Agencies and lobbying agencies, our policy network has done a lot of work to lobby for some of those things.

So once they are in policy, it's been a lot easier. So without policy work, some things have not advanced as much as you would think. So those are the general challenges that I can, did I address your question correctly?

So once they are in policy, it's been a lot easier. So without policy work, some things have not advanced as much as you would think. So those are the general challenges that I can, did I address your question correctly?

I think we looked at a variety of resources. And although I was not in the leadership team at the time, I am

I think we looked at a variety of resources. And although I was not in the leadership team at the time, I am

almost certain that we did you know we we did follow a lot of guidelines and healthy people 2020 must have been one of them as well yeah i can imagine that i can't imagine that not being a resource that we so we we solicit help from a lot of resources and information and then ultimately we you know vetted with the communities and those that are going to actually do the work

almost certain that we did you know we we did follow a lot of guidelines and healthy people 2020 must have been one of them as well yeah i can imagine that i can't imagine that not being a resource that we so we we solicit help from a lot of resources and information and then ultimately we you know vetted with the communities and those that are going to actually do the work

to see what's most feasible and what speaks to them. Because if it is not addressing the local burden and if it has not got the engagement of our partners, it's not going to go anywhere. So long story, you know, the crux of it is yes, I'm sure we looked at healthy people. We've looked at many other parameters. There's the Minnesota Community Measurement Resource.

to see what's most feasible and what speaks to them. Because if it is not addressing the local burden and if it has not got the engagement of our partners, it's not going to go anywhere. So long story, you know, the crux of it is yes, I'm sure we looked at healthy people. We've looked at many other parameters. There's the Minnesota Community Measurement Resource.

There's a variety of resources that establish many things around cancer burden cure treatment, availability, access, community resources. it's a, it's a composite picture. I know mine doesn't seem straightforward, but what I'm saying is it probably was one of the reasons.

There's a variety of resources that establish many things around cancer burden cure treatment, availability, access, community resources. it's a, it's a composite picture. I know mine doesn't seem straightforward, but what I'm saying is it probably was one of the reasons.